Featured products
-
peptide
5-amino-1mq
Rated 0 out of 5$120.00Original price was: $120.00.$16.00Current price is: $16.00. -
peptide
Adipotide
Rated 0 out of 5$100.00Original price was: $100.00.$90.00Current price is: $90.00. -
peptide
Botulinum toxin
Rated 0 out of 5$350.00Original price was: $350.00.$309.00Current price is: $309.00. -
peptide
BPC157 10mg + TB500 10mg
Rated 0 out of 5$250.00Original price was: $250.00.$208.00Current price is: $208.00. -
peptide
BPC157 5mg + TB500 5mg
Rated 0 out of 5$150.00Original price was: $150.00.$115.00Current price is: $115.00.
Customized service
Factory source shipment, supplier bulk purchase please contact us, price negotiated by private message. Service available, bottle cap color customization optional, label sticker service available, plastic packaging box available for separate sale.
Our Mission
Adheres to the brand concept of “innovation leads, technology applies, peptides open the future” and is committed to becoming a leader in the field of biotechnology.
Contact WhatsApp: +86 1561 825 875
Tirzepatide
Tirzepatide, an innovative dual receptor agonist, has shown great potential in the treatment of obesity and diabetes. Its significant weight loss effect and good market performance make it one of the high-profile drugs in this field. However, patients should also pay attention to possible adverse reactions and contraindications when using it, and use it rationally under the guidance of a doctor.
Semaglutide
Semaglutide is a new diabetes drug with multiple therapeutic benefits, with impressive performance in lowering blood sugar, reducing weight and improving cardiovascular health. However, patients still need to pay attention to possible side effects during use and use the medication rationally under the guidance of a doctor.
Retatrutide
According to clinical trial data, various doses of retatrutide treatment showed clinically significant weight loss, with greater weight loss in women.
In addition, retatrutide significantly improved all lipid levels except HDL and had significant benefits on patients’ diastolic and systolic blood pressure.
Retatrutide, as a new multiple receptor agonist drug, shows great potential in the treatment of obesity and NAFLD/NASH. As clinical trials progress, it is expected to become one of the important drugs in the treatment of these diseases.












